Choline attenuates inflammatory hyperalgesia activating nitric oxide/cGMP/ATP-sensitive potassium channels pathway.


Journal

Brain research
ISSN: 1872-6240
Titre abrégé: Brain Res
Pays: Netherlands
ID NLM: 0045503

Informations de publication

Date de publication:
15 01 2020
Historique:
received: 01 11 2018
revised: 18 11 2019
accepted: 23 11 2019
pubmed: 30 11 2019
medline: 11 3 2021
entrez: 30 11 2019
Statut: ppublish

Résumé

New findings on neural regulation of immunity are allowing the design of novel pharmacological strategies to control inflammation and nociception. Herein, we report that choline, a 7-nicotinic acetylcholine receptor (α7nAChRs) agonist, prevents carrageenan-induced hyperalgesia without affecting inflammatory parameters (neutrophil migration or cytokine/chemokines production) or inducing sedation or even motor impairment. Choline also attenuates prostaglandin-E

Identifiants

pubmed: 31783002
pii: S0006-8993(19)30621-3
doi: 10.1016/j.brainres.2019.146567
pmc: PMC7054728
mid: NIHMS1556093
pii:
doi:

Substances chimiques

KATP Channels 0
alpha7 Nicotinic Acetylcholine Receptor 0
Nitric Oxide 31C4KY9ESH
Freund's Adjuvant 9007-81-2
Cyclic GMP H2D2X058MU
Dinoprostone K7Q1JQR04M
Choline N91BDP6H0X

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

146567

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM114180
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Références

Life Sci. 2004 Apr 2;74(20):2577-91
pubmed: 15010267
Pharmacol Ther. 2006 Oct;112(1):116-38
pubmed: 16730375
Nitric Oxide. 2011 Oct 30;25(3):243-54
pubmed: 21723953
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3680-5
pubmed: 14990791
J Neurosci. 1999 Mar 15;19(6):2181-6
pubmed: 10066271
Expert Opin Investig Drugs. 2001 Oct;10(10):1819-30
pubmed: 11772288
Pain. 2010 Sep;150(3):542-9
pubmed: 20619541
Pharmacol Biochem Behav. 2013 Sep;110:19-26
pubmed: 23747933
Nature. 2003 Jan 23;421(6921):384-8
pubmed: 12508119
Eur J Neurosci. 1997 Dec;9(12):2734-42
pubmed: 9517478
Pain. 1987 Feb;28(2):201-22
pubmed: 3547255
Mol Med. 2008 Sep-Oct;14(9-10):567-74
pubmed: 18584048
Pain. 1996 Mar;64(3):493-501
pubmed: 8783314
J Invest Dermatol. 1982 Mar;78(3):206-9
pubmed: 6276474
Eur J Pharmacol. 1991 Aug 16;201(1):121-2
pubmed: 1665419
Eur J Pharmacol. 1994 Jan 14;251(2-3):173-9
pubmed: 7908638
Science. 2011 Oct 7;334(6052):98-101
pubmed: 21921156
Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):11008-13
pubmed: 18669662
J Leukoc Biol. 2008 Apr;83(4):824-32
pubmed: 18203872
Life Sci. 2003 Aug 15;73(13):1609-15
pubmed: 12875893
Neuroscience. 2005;132(1):49-56
pubmed: 15780465
Neuropharmacology. 2014 Apr;79:37-48
pubmed: 24225197
Pain. 1996 Sep;67(1):97-106
pubmed: 8895236
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4442-7
pubmed: 20147620
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1755-60
pubmed: 15665080
Histochem Cell Biol. 2003 Sep;120(3):173-81
pubmed: 12898272
Biochem Pharmacol. 2013 Oct 15;86(8):1201-7
pubmed: 23811428
J Pharmacol Exp Ther. 1997 Mar;280(3):1117-36
pubmed: 9067295
Eur J Pharmacol. 1992 Jul 7;217(2-3):225-7
pubmed: 1330593
Anesthesiology. 2003 Oct;99(4):1023-7
pubmed: 14508341
J Pain. 2008 Jul;9(7):580-7
pubmed: 18420461
Neurosci Lett. 1996 Aug 9;213(3):201-4
pubmed: 8873149
Front Cell Neurosci. 2017 Jul 05;11:189
pubmed: 28725182
Reg Anesth Pain Med. 2002 Sep-Oct;27(5):514-6
pubmed: 12373702
Braz J Med Biol Res. 2004 Mar;37(3):401-7
pubmed: 15060710
J Immunol. 2011 Apr 1;186(7):4340-6
pubmed: 21339364
Neurosci Lett. 2013 Aug 26;548:291-5
pubmed: 23769729
Neuropsychopharmacology. 2000 May;22(5):451-65
pubmed: 10731620
Pain. 2000 Oct;88(1):1-6
pubmed: 11098093
Neuropharmacology. 2000 Oct;39(13):2785-91
pubmed: 11044748
Basic Clin Pharmacol Toxicol. 2016 Nov;119(5):453-457
pubmed: 27098245
Eur J Pharmacol. 1975 Apr;31(2):250-60
pubmed: 1149792
Br J Anaesth. 2010 Aug;105(2):201-7
pubmed: 20511332
Nat New Biol. 1972 Dec 13;240(102):200-3
pubmed: 4629913
Nature. 2000 May 25;405(6785):458-62
pubmed: 10839541
J Pharmacol Exp Ther. 2006 Jan;316(1):325-35
pubmed: 16192316

Auteurs

Ricardo Kusuda (R)

Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Eleonora Uchôa Carreira (EU)

Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Luis Ulloa (L)

Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University, Durham, NC 27710, USA.

Fernando Queiroz Cunha (FQ)

Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Alexandre Kanashiro (A)

Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Thiago Mattar Cunha (TM)

Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil. Electronic address: thicunha@fmrp.usp.br.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH